Trials / Completed
CompletedNCT00595543
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 166 (estimated)
- Sponsor
- Bp Consulting, Inc · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac | 1 drop (in the eye) Instill one drop in the affected eye twice daily for three months |
| DRUG | Ketorolac | 1 drop (in the eye) Instill one drop in the affected eye four times daily for three months |
| DRUG | Diclofenac | 1 drop (in the eye) Instill one drop in the affected eye four times daily for three months |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-01-16
- Last updated
- 2009-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00595543. Inclusion in this directory is not an endorsement.